Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(22%)
Results Posted
33%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_4
1
11%
Ph not_applicable
8
89%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (11.1%)
N/A8 (88.9%)

Trials by Status

recruiting222%
terminated111%
completed667%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9